Senior insider sale
SVP, Commercial Operations at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$483.8K
8.88K shares
What this filing means
HORICH WILLIAM TODD plans to sell 8.88K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $483.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001950047-26-002419
Officer· SVP, Commercial Operations
Since Mar 2026
8.88K
Shares to sell
$483.8K
Approx. market value
4.44K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted stock vesting under a registered plan
Employee stock unit award(s)
2/28/2026
4.04KRestricted stock vesting under a registered plan
Employee stock unit award(s)
2/23/2026
394.00Total acquired4.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2026 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 4.04K | — |
2/23/2026 | Restricted stock vesting under a registered plan Employee stock unit award(s) | 394.00 | — |
| Total | 4.44K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.44K
Market value
$239.7K
3/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.44K
Market value
$244.1K
3/10/2026
Total
Units
8.88K
Value
$483.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/9/2026 | 4.44K | $239.7K | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 4.44K | $244.1K | NASDAQ | Planned |
| Total | 8.88K | $483.8K | ||